Interestingly, the incidence of Non-Melanoma Skin Cancer in psoriasis patients treated with TNF inhibitors is nearly six times higher compared to RA, underscoring the influence of disease-related factors, such as prior psoriasis phototherapy (27). This evidence concerns the gene TNF and non-melanoma skin carcinoma.